A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein
A Conformationally Gated Model of Methadone and Loperamide Transport by P-Glycoprotein
复制标题
DOI:
10.1016/j.xphs.2018.02.019
复制
发表时间:
2018-07-01
影响因子:
3.8
通讯作者:
Roberts, Arthur G.
中科院分区:
文献类型:
--
作者:
Gibbs, Morgan E.;Wilt, Laura A.;Roberts, Arthur G.
P-glycoprotein (Pgp) is a multidrug resistance transporter that limits the penetration of a wide range of neurotherapeutics into the brain including opioids. The diphenylpropylamine opioids methadone and loperamide are structurally similar, but loperamide has about a 4-fold higher Pgp-mediated transport rate. In addition to these differences, they showed significant differences in their effects on Pgp-mediated adenosine triphosphate (ATP) hydrolysis. The activation of Pgp-mediated ATP hydrolysis by methadone was monophasic, whereas loperamide activation of ATP hydrolysis was biphasic implying methadone has a single binding site and loperamide has 2 binding sites on Pgp. Quenching of tryptophan fluorescence with these drugs and digoxin showed competition between the opioids and that loperamide does not compete for the digoxin-binding site. Acrylamide quenching of tryptophan fluorescence to probe Pgp conformational changes revealed that methadone- and loperamide-induced conformational changes were distinct. These results were used to develop a model for Pgp-mediated transport of methadone and loperamide where opioid binding and conformational changes are used to explain the differences in the opioid transport rates between methadone and loperamide. (C) 2018 American Pharmacists Association (R). Published by Elsevier Inc. All rights reserved.